Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2003
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466698A1 Cellular vaccines comprising adjuvants
05/15/2003CA2466530A1 Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2466050A1 Polyvalent immunogen
05/15/2003CA2466049A1 Human monoclonal antibodies to dendritic cells
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465953A1 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003CA2465731A1 Screening for hepatitis c virus entry inhibitors
05/15/2003CA2465679A1 High level constitutive production of anthrax protective antigen
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464529A1 Method of treating estrogen responsive breast cancer
05/15/2003CA2464007A1 Methods for treating ocular neovascular diseases
05/15/2003CA2462653A1 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
05/14/2003EP1310557A1 Design of bioactive peptides based on immunoglobulin structure
05/14/2003EP1310554A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310551A1 Virus-like micrograins and process for producing the same
05/14/2003EP1310260A1 Mixed chimerism and tolerance
05/14/2003EP1309705A2 Multivalent target binding protein
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309703A2 Kallikrein gene
05/14/2003EP1309700A2 Human phosphodiesterases
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309682A2 Tetraspan protein and uses thereof
05/14/2003EP1309627A1 Immunotherapy for chronic myelocytic leukemia
05/14/2003EP1309625A2 Therapeutic compounds for ovarian cancer
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309617A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof
05/14/2003EP1309602A2 Malaria immunogen and vaccine
05/14/2003EP1309374A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
05/14/2003EP1309373A2 Method and composition for altering a t cell mediated pathology
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309345A2 Cathelicidins as vaccine adjuvants
05/14/2003EP1309344A1 Oral solid dose vaccine
05/14/2003EP1309343A1 Vaccines against cytokines and growth factors derived from malignant tumours
05/14/2003EP1309341A2 Prevention and treatment of alzheimer's disease
05/14/2003EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage
05/14/2003EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/14/2003EP1107787B1 Salmonella typhi vaccine compositions
05/14/2003EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
05/14/2003EP0815255B1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
05/14/2003EP0753065B1 Antibodies against e-selectin
05/14/2003EP0692974B1 Multicomponent clostridial vaccines using saponin adjuvants
05/14/2003EP0666919B1 Vaccine containing a thiol protease
05/14/2003EP0656014B1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
05/14/2003EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine
05/14/2003CN1418253A Proteins producing altered immunogenic response and methods of making and using the same
05/14/2003CN1418248A Altered strain of modified vaccinia virus ankara (MVA)
05/14/2003CN1418115A Coating that promotes endothelial Cell adherence
05/14/2003CN1418106A 疫苗 Vaccine
05/14/2003CN1418105A Use of MIA in immunotherapy
05/14/2003CN1417329A Polyepitope malaria vaccine and its encoding gene
05/14/2003CN1417223A CR1 gene related to cell reconstitution, conduction and death
05/14/2003CN1416899A Prepn of cancer-treating medicine
05/14/2003CN1416898A Prepn process of specific fusion vaccine
05/14/2003CN1416897A Prepn process of expression library fusion vaccine
05/14/2003CN1416896A Tumor CT antigen immune inducing agent for treating liver cancer and its prepn
05/13/2003WO2004039826A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003WO2002040048A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003US6564114 Intensity data, computer
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562801 PpGpp and pppGpp as immunomodulatory agents
05/13/2003US6562800 Use of immunopotentiating sequences for inducing immune response
05/13/2003US6562798 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562376 DNA vaccines against poxviruses
05/13/2003US6562352 50 kD C fragment of tetanus toxin, P69 outer membrane protein of B. pertussis, B. pertussis filamentous haemagglutinin and carrier
05/13/2003US6562351 Fusion proteins; genetic engineering
05/13/2003US6562350 Combined vaccine against both HAV and measles virus and method of producing it
05/13/2003US6562349 Otitis media vaccine
05/13/2003US6562347 Eliciting immune response for cancer treatment or human immunodeficiency virus infection prevention or treatment
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003US6562345 Immuno-reactive peptide CTL epitopes of human cytomegalovirus
05/13/2003US6562344 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562336 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
05/13/2003US6561808 Self cleaning using a source of light in the visible range in conjunction with a photosensitive composition; photosensitizer is conjoined with vector molecular fragments to to form a targeting mechanism that can selectively reduce harmful
05/13/2003CA2467719A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003CA2428649A1 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003CA2105998C Human pf4a receptors and their use
05/13/2003CA2105979C Monoclonal antibody against lps core
05/13/2003CA2086131C Anti-human ige monoclonal antibodies
05/08/2003WO2003038128A1 Methods and compositions for the treatment and diagnosis of pain disorders using 57749
05/08/2003WO2003038113A2 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943
05/08/2003WO2003038088A1 Molecular diagnosis method for multiple myeloma
05/08/2003WO2003038072A1 Generation and use of new types of dendritic cells
1 ... 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 ... 1823